Jan 16 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :
* EXPECTED TO RECORD RISE IN NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS DURING 2017
* SEES FY PROFIT ATTRIBUTABLE IN RANGE RMB 184 MILLION TO RMB 244 MILLION Source text for Eikon: Further company coverage:
 